Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.69B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.41B |
| 3 |
Nike
NKE
|
+$1.01B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$877M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$820M |
Top Sells
| 1 |
TC Energy
TRP
|
+$1.15B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$965M |
| 3 |
UnitedHealth
UNH
|
+$598M |
| 4 |
Mastercard
MA
|
+$534M |
| 5 |
Broadcom
AVGO
|
+$494M |
Sector Composition
| 1 | Technology | 21.39% |
| 2 | Financials | 11.42% |
| 3 | Consumer Discretionary | 8.68% |
| 4 | Healthcare | 8.63% |
| 5 | Industrials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3976
Cassava Sciences
SAVA
$112M
| $744K | ﹤0.01% |
496,313
+217,404
| +78% | +$326K |
|
3977
Black Diamond Therapeutics
BDTX
$184M
| $743K | ﹤0.01% |
479,387
-4,449
| -0.9% | -$6.9K |
|
3978
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
$681M
| $742K | ﹤0.01% |
10,599
| – | – |
|
3979
Protalix BioTherapeutics
PLX
$149M
| $741K | ﹤0.01% |
289,461
+239,751
| +482% | +$614K |
|
3980
CureVac
CVAC
$1.21B
| $741K | ﹤0.01% |
267,404
-75,941
| -22% | -$210K |
|
3981
BlackRock Advantage Large Cap Income ETF
BALI
$427M
| $737K | ﹤0.01% |
+25,587
| New | +$737K |
|
3982
WisdomTree US SmallCap Earnings Fund
EES
$643M
| $734K | ﹤0.01% |
15,029
| – | – |
|
3983
American Outdoor Brands
AOUT
$112M
| $731K | ﹤0.01% |
60,110
+22,232
| +59% | +$270K |
|
3984
Standard BioTools
LAB
$539M
| $731K | ﹤0.01% |
676,529
-496,941
| -42% | -$537K |
|
3985
Ponce Financial Group
PDLB
$338M
| $728K | ﹤0.01% |
57,455
-17,803
| -24% | -$226K |
|
3986
West Bancorporation
WTBA
$353M
| $728K | ﹤0.01% |
36,494
-10,411
| -22% | -$208K |
|
3987
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$413M
| $728K | ﹤0.01% |
8,887
-29,747
| -77% | -$2.44M |
|
|
SRTA
3988
Strata Critical Medical Inc
SRTA
$476M
| $727K | ﹤0.01% |
266,414
-106,618
| -29% | -$291K |
|
3989
iShares MSCI Ireland ETF
EIRL
$59.7M
| $726K | ﹤0.01% |
12,276
-2,978
| -20% | -$176K |
|
3990
Zentalis Pharmaceuticals
ZNTL
$110M
| $726K | ﹤0.01% |
456,393
-461,714
| -50% | -$734K |
|
3991
Tyra Biosciences
TYRA
$673M
| $725K | ﹤0.01% |
78,006
+13,896
| +22% | +$129K |
|
3992
Greif Class B
GEF.B
$2.4B
| $725K | ﹤0.01% |
12,233
-6,718
| -35% | -$398K |
|
3993
Evolution Petroleum
EPM
$185M
| $724K | ﹤0.01% |
139,715
+27,068
| +24% | +$140K |
|
3994
Enanta Pharmaceuticals
ENTA
$166M
| $720K | ﹤0.01% |
130,410
+6,549
| +5% | +$36.2K |
|
|
MUU
3995
Direxion Daily MU Bull 2X Shares
MUU
$64.9M
| $716K | ﹤0.01% |
+50,000
| New | +$716K |
|
3996
Aldeyra Therapeutics
ALDX
$295M
| $715K | ﹤0.01% |
124,365
-115,969
| -48% | -$667K |
|
|
BBNX
3997
Beta Bionics
BBNX
$985M
| $715K | ﹤0.01% |
+58,422
| New | +$715K |
|
3998
Aura Biosciences
AURA
$385M
| $713K | ﹤0.01% |
121,644
-32,410
| -21% | -$190K |
|
3999
AdvisorShares Ranger Equity Bear ETF
HDGE
$50.8M
| $713K | ﹤0.01% |
40,000
| – | – |
|
4000
First Western Financial
MYFW
$228M
| $712K | ﹤0.01% |
36,257
-12,152
| -25% | -$239K |
|